Evidence map›Paper›PMID 25075125›Full record

ArticleBlood2014

BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism.

Claire Mayeur, Patricio A Leyton, Starsha A Kolodziej, Binglan Yu, Kenneth D Bloch

Abstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 70 citations in OpenAlex.

  1. The Effect of Vitamin DInternational journal of environmental research and public health · 2020
    Trial
  2. The neogenin-hemojuvelin axis in murine liver is crucial for hepcidin expression.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Managing the Dual Nature of Iron to Preserve Health.International journal of molecular sciences · 2023
    Review
  7. Iron Homeostasis and Energy Metabolism in Obesity.Clinical nutrition research · 2022
    Review
  8. Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis.Pharmaceuticals (Basel, Switzerland) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Claire MayeurAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, and.
Patricio A LeytonAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, and.
Starsha A KolodziejAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, and.
Binglan YuAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, and.
Kenneth D BlochAnesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care, and Pain Medicine, and Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Geriatric Research Education and Clinical Center · USMassachusetts General Hospital · US

Funding

Modulation of Hepcidin-Ferroportin Signaling using Small MoleculesR01DK082971 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BLOCH, DONALD B, PETERSON, RANDALL T · 2009 to 2018
$4.5M
NIDDK NIH HHS R01 DK082971NIDDK NIH HHS R01DK082971
6 · The paper itself

Abstract

Expression of hepcidin, the hepatic hormone controlling iron homeostasis, is regulated by bone morphogenetic protein (BMP) signaling. We sought to identify which BMP type II receptor expressed in hepatocytes, ActR2a or BMPR2, is responsible for regulating hepcidin gene expression. We studied Bmpr2 heterozygous mice (Bmpr2(+/-)), mice with hepatocyte-specific deficiency of BMPR2, mice with global deficiency of ActR2a, and mice in which hepatocytes lacked both BMPR2 and ActR2a. Hepatic hepcidin messenger RNA (mRNA) levels, serum hepcidin and iron levels, and tissue iron levels did not differ in wild-type mice, Bmpr2(+/-) mice, and mice in which either BMPR2 or ActR2a was deficient. Deficiency of both BMP type II receptors markedly reduced hepatic hepcidin gene expression and serum hepcidin levels leading to severe iron overload. Iron injection increased hepatic hepcidin mRNA levels in mice deficient in either BMPR2 or ActR2a, but not in mice deficient in both BMP type II receptors. In addition, in mouse and human primary hepatocytes, deficiency of both BMPR2 and ActR2a profoundly decreased basal and BMP6-induced hepcidin gene expression. These results suggest that BMP type II receptors, BMPR2 and ActR2a, have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism.

Indexed as

Gene Expression RegulationActin-Related Protein 2AnimalsBone Morphogenetic Protein Receptors, Type IIFemaleGene DeletionHepatocytesHepcidinsHeterozygoteHumansIronIron OverloadLiverMiceMice, KnockoutMutationActin-Related Protein 2Bone Morphogenetic Protein Receptors, Type IIHepcidinsIronRNA, Messenger

Identifiers

PMID25075125
PMCPMC4186540
OpenAlexW2031409131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.